Therapeutic Solutions International
Focus: Therapeutic Solutions International is a California-based biotechnology company specializing in cell therapy and gene therapy with a commercial portfolio anchored by ADZENYS XR-ODT, an extended-release ADHD treatment. The company operates at mid-cap biotech scale with a heavy reliance on legacy CNS stimulant assets.
Profile data last refreshed 11h ago · AI intelligence enriched 1w ago
Open Jobs
0
About Therapeutic Solutions International
AI assessmentNot HiringNo open roles listed right now. Follow Therapeutic Solutions International to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from Therapeutic Solutions International's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Early-stage
5 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Help build intelligence for Therapeutic Solutions International
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.